Business
-
Even as He Faces Prison Time, Binance’s Founder Plans a Comeback
Since pleading guilty to violating money-laundering rules, Changpeng Zhao, who ran the giant crypto exchange Binance, has networked across the United States to set up his next act.
-
Paramount’s Chief Executive, Bob Bakish, Steps Down
Mr. Bakish was once a staunch ally of Shari Redstone, Paramount’s controlling shareholder. His departure comes as the company considers a major merger.
-
Environmental Prize Highlights Work to Keep Fossil Fuels at Bay
Around the world, grass-roots organizers and Indigenous communities are taking proposed coal, oil and gas projects to court — and winning.
-
Inflation Is Stubborn. Is the Federal Budget Deficit Making It Worse?
Economists are divided over whether the growing amount of federal borrowing is fueling demand and driving up prices.
-
Skydance Offers Paramount a Deal Sweetener: A $3 Billion Cash Infusion
The terms of the new deal would provide Paramount shareholders with an investment to pay down debt and buy back stock.
-
Blinken Tours China to Promote Some Ties, While the U.S. Severs Others
Tensions over economic ties are running high, threatening to disrupt a fragile cooperation between the U.S. and China.
-
Who Gains from Elon Musk’s Visit to China?
Tesla’s C.E.O. appears to have landed a deal that moves the company closer to bringing fully autonomous driving to a giant market. But Beijing is keen to exploit the visit for its own purposes.
-
A Return to New York and, Finally, an Apartment She Can Afford
After moving 10 times in 10 years, a woman found that a little luck was the best companion for a lot of hard work. She won a studio in a lottery on her fifth try.
-
A.I. Start-Ups Face a Rough Financial Reality Check
The table stakes for small companies to compete with the likes of Microsoft and Google are in the billions of dollars. And even that may not be enough.
-
How Supplement Stores Are Trying to Tap Into the Ozempic Boom
GNC and the Vitamin Shoppe are redesigning displays and taking other steps to appeal to people who are taking or are interested in drugs like Ozempic and Wegovy.